Tissue Diagnostics Market: Meticulous Research® Reveals Why This Market is Growing at a CAGR of 7.4% to Reach $8.52 Billion by 2029
A global rise in cancer prevalence has led to advancements in diagnostic techniques. As per GLOBOCAN 2020, the prevalence of cancer is estimated at 19,292,789 cases worldwide, out of which the estimated prevalence of breast cancer is 2,261,419 cases. The rising geriatric population and the increasing prevalence of cancer have increased the burden on healthcare systems in major countries such as the U.S., Japan, and China. Tissue diagnostics is an important diagnostic technique for diseases such as cancer. The rising focus on personalized medicines is gradually increasing the use of tissue diagnostics for understanding the prognosis of diseases.
In its latest publication on tissue diagnostics, Meticulous Research® states that the global Tissue Diagnostics Market is projected to reach $8.52 Billion by 2029, at a CAGR of 7.4% from 2022 to 2029.
The global tissue diagnostics market is segmented by Product Type (Consumables [Antibodies, Kits, Reagents], Instruments [Slide Staining Systems, Slide Scanners, Tissue Processing Systems, Other Instruments ;]